Letter to FTC Re: Supplements Marketed as Opioid Withdrawal Aids

CSPI writes FTC Acting Chairman Maureen K. Olhausen urging the agency to take enforcement action to protect consumers from dietary supplements that are marketed as opioid withdrawal aids.